Table 5.
Quartiles of plasma vitamin B6 concentration (median, range pmol/L)
|
|||||
---|---|---|---|---|---|
Log2(vitamin B6) | 14.3 (0.1–20.2) | 25.7 (20.3–34.0) | 43.0 (34.1–59.7) | 89.4 (60.4–480.0) | |
Person-years | 10,106 | 2343 | 2419 | 2829 | 2515 |
Cases | 85 | 23 | 22 | 17 | 23 |
Model 1 | 0.89 (0.77–1.03) | 1 | 0.69 (0.31–1.54) | 0.64 (0.27–1.50) | 0.53 (0.24–1.21) |
Model 2 | 0.88 (0.74–1.05) | 1 | 0.72 (0.33–1.58) | 0.70 (0.23– 2.14) | 0.49 (0.20–1.20) |
Model 3 | 0.91 (0.77–1.09) | 1 | 1.05 (0.45–2.44) | 0.81 (0.32–2.03) | 0.49 (0.17–1.38) |
| |||||
Quartiles of plasma vitamin B12 concentration (median, range pmol/L)
|
|||||
Log2(vitamin B12) | 162.0 (40.0–200.0) | 235.0 (201.0–280.0) | 323 (281.0–367.0) | 449 (368.0–1217.0) | |
| |||||
Person-years | 10,106 | 2562 | 2515 | 2493 | 2535 |
Cases | 88 | 25 | 28 | 14 | 18 |
Model 1 | 0.70 (0.46–1.07) | 1 | 0.84 (0.37–1.88) | 0.60 (0.25–1.47) | 0.55 (0.24–1.28) |
Model 2 | 0.77 (0.50–1.17) | 1 | 0.89 (0.37–2.12) | 0.59 (0.24–1.47) | 0.58 (0.25–1.33) |
Model 3 | 0.75 (0.42–1.34) | 1 | 0.55 (0.22–1.39) | 0.52 (0.20–1.37) | 0.70 (0.28–1.76) |
| |||||
Quartiles of plasma folate concentration (median, range pmol/L)
|
|||||
Log2(folate) | 1.4 (0.3–3.2) | 5.3 (3.3–7.1) | 9.3 (7.2–12.9) | 18.4 (13.2–60.1) | |
| |||||
Person-years | 10,106 | 2590 | 2402 | 2563 | 2551 |
Cases | 88 | 23 | 26 | 21 | 15 |
Model 1 | 0.85 (0.69–1.06) | 1 | 0.65 (0.28–1.48) | 0.69 (0.29–1.67) | 0.43 (0.19–0.99) |
Model 2 | 0.89 (0.72–1.11) | 1 | 0.85 (0.33–2.16) | 0.97 (0.39–2.43) | 0.45 (0.19–1.09) |
Model 3 | 0.90 (0.69–1.18) | 1 | 1.03 (0.34–3.14) | 1.45 (0.55–3.85) | 0.41 (0.12–1.43) |
Model 1: Adjusted for age, sex, race, field center.
Model 2: Adjusted for Model 1 + body mass index, height, systolic and diastolic blood pressure, anti-hypertension medication, diabetes mellitus, smoking status, drinking status, and, left ventricular hypertrophy.
Model 3: Adjusted for Model 2 + time-varying coronary heart disease and heart failure.